Clinical Trial Update: Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring uric acid reduction as a treatment for pediatric chronic kidney disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperuricemia

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Hyperuricemia, Chronic Kidney Diseases | Phase 2 | Status: TERMINATED | Results posted: 2021-05-27